Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cellsSeiga Ohmine(Mayo Clinic), Yasuhiro Ikeda(AstraZeneca (Netherlands))Stem Cell Research & TherapyNovember 16, 201110.1186/scrt87Cited by 39SaveCiteExport RISWatch citationsRelated PapersReprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency|Aging|2012|85Cytoplasmic Body Component TRIM5α Requires Lipid-enriched Microdomains for Efficient HIV-1 Restriction|Journal of Biological Chemistry|2010|10